A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
Clinical trial NCT06474416 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06474416
- Sponsor
- Shanghai BDgene Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-04
- Primary completion
- 2025-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.